Immune Cell Banking: Securing Your Health with Future-Ready Innovations

Why Choose EHL BIO for Immune Cell Banking?

Immunity is the most critical defense mechanism, eliminating foreign substances and aged cells to maintain health. However, as we age, immune cell efficiency may decline or become imbalanced, leading to chronic infections or autoimmune conditions. EHL BIO offers innovative Immune Cell Banking as health insurance at the cellular level. We possess specialized expertise in isolating and culturing various immune cells, including NK Cells, T Cells, Dendritic Cells, and iNKT Cells.

With advanced technology accumulated since 2012, we focus on preserving quality of life and extending lifespan through modern regenerative medicine. Storing cells while the body is healthy ensures the highest quality cells are ready for future use. Each individual's treatment and restoration plan is subject to assessment by EHL BIO's expert medical and scientific teams to ensure it truly meets personalized needs.

Production Standards and Maximum Safety

EHL BIO prioritizes safety and quality in every production step. Our GMP (Good Manufacturing Practices) facility is certified by Korean regulatory authorities, and we are the first in Korea to be licensed as a Human Cell Management Business under the Modern Regenerative Medicine and Biopharmaceuticals Act. Our facilities include Class 100 cleanrooms and high-standard equipment such as Biological Safety Cabinets and high-efficiency HEPA filtration systems.

Our banking process utilizes Apheresis technology, allowing for the harvest of massive cell quantities—up to 30 times more than standard blood draws. This enables a single collection to be used for multiple recovery sessions, reducing patient burden and anxiety. Cells are preserved in liquid nitrogen tanks at -196°C to maintain their youthful state and peak efficiency until they are needed for use.

Banking your immune cells today is the ultimate health insurance for your future.

Immune Cell Innovations for Future Recovery

Current medical progress focuses on Cell Therapy for restoration and quality of life goals as assessed by the EHL team. Research and development of products like Keycell-IM—immune cells extracted from the patient’s own blood, isolated and cultured with EHL BIO’s proprietary technology—represent a new hope for physical recovery. Immune cell therapy aims to eliminate abnormal cells, reduce the likelihood of side effects from traditional treatments, and promote long-term health.

Using combined groups of multiple immune cells for higher efficacy is a new technique we specialize in, currently in the medical development stage for application across various conditions, whether for age-related decline or internal system strengthening. EHL BIO remains committed to collaborative research with top universities and a network of over 100 partner hospitals in Korea to provide the most advanced medical technology to all clients.

Convenient and Systematic Service Process

For those interested from Thailand, EHL Thailand provides a Thai-speaking coordination team to guide you closely. The process starts with an online consultation, followed by a preliminary health document assessment and travel planning by our medical team. Upon arrival at EHL Cell Clinic in Seoul, Korea, you will undergo physical examinations and cell collection by our specialists.

Following collection, cells enter the culturing process in our standardized GMP center, subject to rigorous quality control before being administered according to the plan. After the process and returning to Thailand, our team will continue to follow up, ensuring you achieve the best results in restoring health and quality of life. This is EHL BIO’s commitment to merging medical and pharmaceutical technologies for the future of humanity.